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The current interest in hydroxamic and polyhydroxamic acids is related to the vari-
ety of their biological activities, as well as to their role as iron chelators and microbial
siderophores (13). Antibacterial, antifungal, antitumor and anti-inflammatory activities
of hydroxamic acids are connected with their ability to inhibit various enzymes, viz.,
matrix metalloproteinases (4, 5), 5-lipoxygenase (6, 7), urease (8) or ribonucleotid reduc-
tase (9). Some ion exchange resins are based on hydroxamic acids (10), and a number of
hydroxamic acids are currently accepted therapeutic agents (desferrioxamine B, hydro-
xycarbamide, ibuproxam, oxametacin, bufexamac, adrafinil) (11). The promising thera-
peutic potential of this class of compounds prompted us to screen antimicrobial activity
of several hydroxamic acids previously synthesized by our group (12). In this paper, we
report the results of the undertaken antimicrobial evaluation.
EXPERIMENTAL
Melting points were determined on a Boëtius Microheating Stage (Franz Küstner
Nachf. KG, Germany). IR spectra were recorded on a FTIR Perkin Elmer Paragon 500
spectrometer (Perkin Elmer, UK). For TLC, silica gel plates Kieselgel 60 F254 (Merck, Ger-
many) and the following solvent mixtures were used: i-propanol/conc. ammonium hy-
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Several hydroxamic acids, viz., N-benzyl-N’-hydroxysuc-
cinamide (BHS) (1), poly-(N-hydroxy)-DL-asparta-
mide (PHA) (2), poly-N-hydroxy-N-methyl-DL-as-
partamide (PMHA) (3) and poly -N-hydroxy)-DL-
aspartamide	poly-N-2-hydroxyethyl)-DL-aspartami-
de (PHA-PHEA 1:1) (4) were prepared and screened for
their antimicrobial activity. Ten Gram-positive and 7 Gram-
-negative species of bacteria, 5 Candida species, 4 derma-
tophyte species and 3 mould species were used in tests.
Compound 1 showed no antimicrobial activity on any of
the tested microorganisms. Other compounds (2–4) show-
ed a narrow spectrum of antibacterial activity, but no an-
tifungal activity.
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droxide/water (7:1:2) and chloroform/methanol (7:3). Spots were visualized by short-
wave UV light and iodine vapour.
L-aspartic acid was purchased from Kemika (Croatia), while N-methylhydroxylamine
hydrochloride and N-methylhydroxylamine hydrochloride were purchased from Aldrich
(USA). All solvents were of analytical grade purity and were dried prior to use.
Syntheses
Hydroxamic and polyhydroxamic acids were prepared according to previously de-
scribed procedures. Melting points, IR and TLC data were in agreement with the pub-
lished data.
N-benzyl-N’-hydroxysuccinamide (BHS) (1).  The compound was synthesized by a
slightly modified procedure published previously (13). To a solution of N-hydroxysucci-
nimide (4.59 g, 0.004 mol) in ethanol (40 mL), benzylamine (4.28 g, 0.004 mol) was added
dropwise. The reaction mixture was stirred one day at room temperature, then refluxed
2.5 h and left overnight. The precipitated product was filtered off, washed with ethanol
and dried in vacuum at 40 
C, under P2O5. Yield: 7.69 g (86%). m.p. 144146 °C; m.p.
(13) 149 °C.
Poly-(N-hydroxy)-DL-aspartamide (PHA) (2).  Polyhydroxamic acid 2 was pre-
pared by aminolysis of the succinimide units of poly-DL-(2,5-dioxo-1,3-pyrrolidinediyl)
(PSI) by hydroxylamine, according to our procedure published previously (12). PSI was
prepared by thermal polycondensation of L-aspartic acid (14, 15).
Poly-N-hydroxy-N-methyl-DL-aspartamide (PMHA) (3).  Polymeric compound
3 was prepared by aminolysis of PSI by N-methylhydroxylamine (12).
Poly-N-hydroxy)-DL-aspartamide-poly-N-2-hydroxyethyl)-DL-aspartamide
(PHA-PHEA) (4).  This copolymer was synthesized by partial aminolysis of PSI by hy-
droxylamine and further aminolysis by 2-aminoethanol (12). The ratio of PHA and PHEA
units was 1:1. Structures of the tested compounds are shown in Fig. 1.
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Fig. 1. Chemical structure of N-benzyl-N’-hydroxysuccinamide (BHS) (1), poly-(N-hydroxy)-
-DL-aspartamide (PHA) (2), poly-N-hydroxy-N-methyl-DL-aspartamide (PMHA) (3) and po-
ly-N-hydroxy)-DL-aspartamide	poly-N-2-hydroxyethyl)-DL-aspartamide (PHA-PHEA1:1) (4).
Microorganisms tested
Investigated microorganisms (17 species of Gram-positive and Gram-negative bac-
teria and 12 species of fungi including yeasts, dermatophytes and moulds) are listed in
Table I. All tested species were from the collection of the Department of Microbiology,
Faculty of Pharmacy and Biochemistry, University of Zagreb, Croatia. Gram-positive
and Gram-negative bacteria were cultivated on Müller-Hinton agar (Merck, Germany)
(MHA) while Streptococcus pyogenes ATCC 110401 was cultivated on blood agar (BA).
Yeasts and moulds were cultivated on Sabouraud 2%-glucose agar (SGA) (Biolife, Italy)
supplemented with 50 mg L–1 chloramphenicol. Dermatophytes were also cultivated on
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Table I. Antimicrobial activity of compounds 1–4 determined by the difusion method
Microorganism
Inhibition zone diameters (mm)
1 2 3 4
Gram-positive bacteria
Bacillus subtilis NCTC 8236

32

32
Bacillus pumilus NCTC 8241

20

18
Bacillus cereus ATCC 11778
   
Bacillus stearothermophilus MFBF

26

16
Staphylococcus aureus ATCC 29213 14 14 18 14
Staphylococcus aureus ATCC 25923
   
Staphylococcus epidermidis MFBF
 
17 12
Sarcina lutea ATCC 9341

33

26
Enterococcus faecalis R-13
   
Enterococcus faecalis ATCC 29212

25 17 17
Streptococcus pyogenes ATCC 20478
   
Streptococcus pyogenes ATCC 110401

23a

23a
Listeria monocytogenes MFBF

17

20
Listeria monocytogenes R1

25

21
Listeria monocytogenes R15

26

23
Gram-negative bacteria
Klebsiella oxytoca MFBF
   
Serratia sp. MFBF
   
Pseudomonas aeuruginosa 14

21
 
Pseudomonas aeuruginosa R-301
   
Pseudomonas aeuruginosa 91 15b 18 21

Pseudomonas aeuruginosa 8
   
Pseudomonas aeuruginosa 39R
   
Proteus mirabilis MFBF
 
16

Proteus mirabilis R-611
   
Proteus mirabilis R-624
   
Yersinia enterocolitica R1
 
23 17
Yersinia enterocolitica R15
 
20 13
Shigella sonnei MFBF

12 19

Acinetobacter sp. MFBF
   
SGAwith addition of 50 mg L–1 cycloheximide to prevent growth of other microorganisms.
All tested yeasts were cultivated for 72 h at 25  2 °C and dermatophytes and moulds for
7 days for inoculums preparation.
Antimicrobial investigation
Prior to the analysis, substance 1 was dissolved in 80% ethanol to a final concentration
of 0.025 g mL–1. Substances 2–4were dissolved in sterile distilled water to final concentrations
of 0.157 g mL–1 (2), 0.123 g mL–1 (3) and 0.079 g mL–1. Antimicrobial activity of compounds
1–4 was tested by the agar diffusion method described in European Pharmacopoeia (16).
For the agar diffusion method, 25  2 mL of sterile and melted MHA and/or BA and
SGA at 4550 °C was inoculated with 1 mL of approximately 108 CFU mL–1 of bacterial
cells and 15  106 CFU mL–1 of yeast cells or conidia and mycelial structures of derma-
tophytes and moulds in sterile saline in Petri dishes (9 cm diameter). Density of bacterial
inoculum was measured with McFarland’s standard solution of freshly prepared barium
sulphate in sterile water (density of 0.1 mL of 1% BaCl2 in 9.9 mL of 1% H2SO4 equals
approximately 3  108 bacterial cells mL–1).
After drying MHA, BA and SGA at room temperature for a maximum of 30 minutes,
holes of 6 mm in diameter were made with stainless steel cylinders and filled with solu-
tions of the tested compounds: 50 µL of each compound for Bacillus subtilis; 30 µL (1), 20
µL (2) 10 µL (3 and 4) for the other microorganisms tested. Plates were then incubated at
4 °C for 1 hour and at 25  2 °C for 24 h for bacteria, 48 h for yeasts and 37 days for
dermatophytes and moulds. After the incubation period, inhibition zones were mea-
sured and recorded.
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Microorganism
Inhibition zone diameters (mm)
1 2 3 4
Yeasts MFBF
Candida albicans
   
Candida tropicalis
   
Candida kefyr
   
Candida krusei
   
Candida glabrata
 
14 13
Dermatophytes MFBF
Microsporum gypseum
   
Microsporum canis
   
Trichophyton menthagrophytes
   
Trichophyton rubrum
   
Moulds MFBF
Aspergillus flavus
   
Fusarium sp.
   
Penicillium sp.
   
a In a very short period compounds 1 and 4 caused hemolysis of the blood agar used for Streptococcus pyogenes
ATCC 11435 culture. b The tested compound has bacteriostatic activity. – no antibacterial/antifungal activity.
Table I. continued
Minimum microbicidal (MMC) and inhibitory (MIC) concentrations were determi-
ned using the serial broth dilution method (17). MMC was determined by the broth two-
-fold macro-dilution method in nutrition medium containing the test compounds (0.02
100%, V/V) and incubated at 37 
C for bacteria or 25 
C for Candida species. The highest
dilution of the test compound preventing appearance of turbidity was considered to be
the minimum inhibitory concentration. All samples showing no turbidity were subcul-
tured into Müeller Hinton or Sabouraud agar. The highest compound dilution from
which the microorganisms did not recover and grow when transferred to fresh medium
was the MMC.
RESULTS AND DISCUSSION
One hydroxamic (BHS, 1) and three polyhydroxamic acids, viz. PHA (2), PMHA (3)
and PHA-PHEA (4), were tested for their antimicrobial activities. Antimicrobial activi-
ties of the tested substances obtained by the diffusion and dilution methods are pre-
sented in Tables I and II.
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Table II. Minimum microbicidal (MMC) and inhibitory concentrations (MIC) of compounds 1–4
determined by the broth dilution methoda
Microorganisms
1 2 3 4
MMC MIC MMC MIC MMC MIC MMC MIC
Bacillus subtilis NCTC 8236 – – 316.0 39.5 – – 79.33 39.67
Bacillus pumilus NCTC 8241 – – – b – – – b
Bacillus stearothermophilus MFBF – – 29.8 14.9 – – 158.7 79.33
Staphylococcus aureus ATCC 29213 b – 79.0 19.75 – – 317.3 79.0
Staphylococcus epidermidis MFBF – – – – 184.13 5.76 237.98 39.67
Sarcina lutea ATCC 9341 – – 39.5 4.94 – – 158.66 39.67
Enterococcus faecalis ATCC 29212 – – 631.0 316.0 245.73 7.68 386.7 158.66
Listeria monocytogenes MFBF – – 9.88 7.41 – – 79.33 14.88
Listeria monocytogenes R1 – – 3.84 1.92 – – 4.94 2.49
Listeria monocytogenes R15 – – 3.84 1.92 – – 19.84 9.92
Pseudomonas aeuruginosa MFBF 14 – – b – – – – –
Pseudomonas aeuruginosa MFBF 91 b – 9.88 7.41 491.0 245.5 – –
Proteus mirabilis MFBF – – – – 184.13 5.76 – –
Yersinia enterocolitica R1 – – – – 61.38 46.04 59.54 14.88
Yersinia enterocolitica R15 – – – – 92.06 46.04 79.38 19.83
Shigella sonnei MFBF – – b – b – – –
Candida glabrata MFBF – – – – b – b –
a in mg mL–1
b Microorganisms developed resistance to the tested compounds although antimicrobial activity was
determined by the dilution method.
MFBF and R – Number of strains from the collection of microorganisms of the Department of Microbiology,
Faculty of Pharmacy and Biochemistry, University of Zagreb, Zagreb, Croatia; ATCC – American Type Culture
Collection, Rockville, USA; NCTC – National Collection of Type Cultures, London, Great Britain.
Hydroxamic acid 1 showed no antimicrobial activity on most of the Gram-positive
and Gram-negative bacteria. In fact, one strain of Staphylococcus aureus ATCC 29213 and
Pseudomonas aeruginosa 91 developed resistance to the tested compound, although an-
timicrobial activity was observed by the dilution method. Species of Candida, dermato-
phytes and moulds were resistant to compound 1. Similar findings were obtained for Ba-
cillus pumilus, P. aeruginosa, Shigella sonnei and Candida glabrata. These microorganisms
developed resistance to substances 2, 3 and 4, respectively.
Compound 3 showed antimicrobial activity against Staphylococcus epidermidis, En-
terococcus faecalis, P. aeruginosa and Yersinia enterocolitica, but at high concentrations (Ta-
ble II). For example, MMC for P. aeruginosa was found to be 491.0 mg mL–1, which is a
significantly higher concentration compared to MMC of trimethoprim (0.10.125 mg mL–1)
(18) or galangin (0.23 mg mL–1), an active compound in propolis extracts (19).
Gram-positive bacteria were more sensitive than Gram-negative bacteria to the ac-
tivities of compounds 2 and 4. In fact, only P. aeruginosa was sensitive to polyhydroxa-
mic acid 2, while Y. enterocolitica was sensitive to polyhydroxamic acid 4. In addition,
compounds 2 and 4 caused hemolysis of the blood agar and cannot be used for human
treatment. These substances could be used only as disinfectants.
CONCLUSIONS
Hydroxamic and polyhydroxamic acids showed a narrow spectrum of antimicrobial
activity. Minimal bactericidal concentrations of these substances are significantly higher
than MMC of most antimicrobial drugs for human treatment. Also, polyhydroxamic
acids (2 and 4) caused hemolysis of the blood agar and they cannot be used in antimi-
crobial therapy of humans. These compounds could be possibly used in disinfection but
at high concentrations.
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S A @ E T A K
Antimikrobni u~inak nekih hidroksamskih kiselina
STJEPAN PEPELJNJAK, BRANKA ZORC i IVAN BUTULA
U radu je ispitano antimikrobno djelovanje nekoliko hidroksamskih kiselina: N-ben-
zil-N’-hidroksi-sukcinamida (BHS) (1), poli-(N-hidroksi)-DL-aspartamida (PHA) (2),
poli-N-hidroksi-N-metil-DL-aspartamida (PMHA) (3) i poli-N-hidroksi)-DL-
-aspartamid	poli-N-2-hidroksietil)-DL-aspartamid kopolimera (PHA-PHEA) (4).
Antimikrobno djelovanje ispitano je na 10 Gram-pozitivnih i 7 Gram-negativnih bakterija,
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5 vrsta kandida, 4 vrste dermatofita i 3 vrste plijesni. Supstancija 1 ne pokazuje antimi-
krobno djelovanje na ispitivane vrsta bakterija i gljivica. Ostali spojevi (2–4) imaju rela-
tivno slabo antimikrobno djelovanje na Gram-pozitivne i Gram-negativne bakterije i ne
pokazuju antifungalni u~inak.
Klju~ne rije~i: hidroksamska kiselina, polihidroksamska kiselina, antimikrobno djelovanje
Farmaceutsko-biokemijski fakultet Sveu~ili{ta u Zagrebu, Zagreb
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